These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17671978)

  • 21. Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling.
    Rossin A; Derouet M; Abdel-Sater F; Hueber AO
    Biochem J; 2009 Apr; 419(1):185-92, 2 p following 192. PubMed ID: 19090789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
    Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
    Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
    Ohtsuki T; Kikuchi H; Koyano T; Kowithayakorn T; Sakai T; Ishibashi M
    Bioorg Med Chem; 2009 Sep; 17(18):6748-54. PubMed ID: 19682913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death receptor 5 targeting activity-guided isolation of isoflavones from Millettia brandisiana and Ardisia colorata and evaluation of ability to induce TRAIL-mediated apoptosis.
    Kikuchi H; Ohtsuki T; Koyano T; Kowithayakorn T; Sakai T; Ishibashi M
    Bioorg Med Chem; 2009 Feb; 17(3):1181-6. PubMed ID: 19124248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.
    Tur V; van der Sloot AM; Reis CR; Szegezdi E; Cool RH; Samali A; Serrano L; Quax WJ
    J Biol Chem; 2008 Jul; 283(29):20560-8. PubMed ID: 18474604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.
    Li B; Russell SJ; Compaan DM; Totpal K; Marsters SA; Ashkenazi A; Cochran AG; Hymowitz SG; Sidhu SS
    J Mol Biol; 2006 Aug; 361(3):522-36. PubMed ID: 16859704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand dimerization programmed by hybridization to study multimeric ligand-receptor interactions.
    Gorska K; Beyrath J; Fournel S; Guichard G; Winssinger N
    Chem Commun (Camb); 2010 Nov; 46(41):7742-4. PubMed ID: 20852806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
    McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
    J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N; Matsuda-Minehata F; Goto Y; Maeda A; Cheng Y; Nakagawa S; Inoue N; Wongpanit K; Jin H; Gonda H; Li J
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():268-72. PubMed ID: 18638134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).
    Ashkenazi A; Holland P; Eckhardt SG
    J Clin Oncol; 2008 Jul; 26(21):3621-30. PubMed ID: 18640940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner.
    Tang W; Wang W; Zhang Y; Liu S; Liu Y; Zheng D
    Cell Res; 2009 Jun; 19(6):758-67. PubMed ID: 19434100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.
    Rizzardi C; Leocata P; Ventura L; Zweyer M; Brollo A; Schneider M; Melato M
    Anticancer Res; 2009 Apr; 29(4):1137-42. PubMed ID: 19414356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.
    Laguinge LM; Samara RN; Wang W; El-Deiry WS; Corner G; Augenlicht L; Mishra L; Jessup JM
    Cancer Res; 2008 Feb; 68(3):909-17. PubMed ID: 18245494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.
    Lamy V; Roussi S; Chaabi M; Gossé F; Lobstein A; Raul F
    Apoptosis; 2008 Oct; 13(10):1232-42. PubMed ID: 18726190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K; Stacher E; Wurm R; Ploner F; Quehenberger F; Wohlkoenig C; Bálint Z; Polachova J; Olschewski A; Samonigg H; Popper HH; Olschewski H
    Lung Cancer; 2009 Jul; 65(1):98-104. PubMed ID: 19081160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.
    Yanase N; Kanetaka Y; Mizuguchi J
    Oncol Rep; 2007 Oct; 18(4):1031-8. PubMed ID: 17786370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
    Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
    Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.